Position in DHR
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$952,019
-$10,769 QoQ
Shares Held
4,998
-1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.36%
of 13F equity value
Holder Rank
#1,123
of 2,098 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Waycross Investment Management Co holds $952,019 across 1 Diagnostics & Research name. DHR ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
This page
|
4,998 | $952,019 |
All Filings in DHR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $952,019 | 4,998 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $962,788 | 5,078 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,174,588 | 5,131 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,049,786 | 5,295 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,080,346 | 5,469 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,165,835 | 5,687 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,306,598 | 5,692 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,601,673 | 5,761 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $1,598,040 | 6,396 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,613,191 | 6,460 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,413,718 | 6,111 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,535,242 | 6,188 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,485,120 | 6,188 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,566,680 | 6,216 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,665,775 | 6,276 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||